Literature DB >> 13627713

Developments in fibrinolytic therapy for thrombo-embolic disease.

S SHERRY, A P FLETCHER, N ALKJAERSIG.   

Abstract

Entities:  

Keywords:  STREPTODORNASE AND STREPTOKINASE/therapeutic use; THROMBOEMBOLISM/therapy

Mesh：

Substances：

Year:  1959        PMID： 13627713     DOI： 10.7326/0003-4819-50-3-560

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

1.  [ON THE MECHANISM OF FIBRINOLYSIS CAUSED BY STREPTOKINASE].

Authors:  H W SCHMIDT
Journal:  Klin Wochenschr       Date:  1963-12-15

2.  [ARE IN VITRO THROMBOLYSIS EXPERIMENTS APPLICABLE TO INTRA VITAM CONDITIONS?COMMENTS ON THE ARTICLE, "THERAPEUTIC FIBRINOLYSIS. STUDIES ON THE EFFECT OF STREPTOKINASE AND ACTASE IN VITRO (I) AND IN VIVO (II)" BY J. JUERGENS].

Authors:  H W SCHMIDT
Journal:  Klin Wochenschr       Date:  1965-06-01

3.  [Lysis of human blood clots in vitro].

Authors:  H ROSOLLECK
Journal:  Klin Wochenschr       Date:  1961-04-15

4.  The Problem of Frostbite in Civilian Medical Practice.

Authors:  Gilbert Hermann; David C Schechter; J Cuthbert Owens; Thomas E Starzl
Journal:  Surg Clin North Am       Date:  1963-04       Impact factor: 2.741

5.  FIBRINOLYTIC THERAPY OF THROMBOPHLEBITIS. TWENTY-FIVE CASES STUDIED WITH SERIAL VENOGRAMS.

Authors:  S P HECKER
Journal:  Calif Med       Date:  1964-07

6.  Resolution of experimental pulmonary emboli with heparin and streptokinase in different dosage regimens.

Authors:  J Hirsh; J F Cade; E Regoeczi; M Gent; M R Buchanan; D M Hynes
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.